M. Pender

Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy
202129 citationsauthor #13
Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis
202119 citationsauthor #6
Hypothesis: bipolar disorder is an Epstein–Barr virus‐driven chronic autoimmune disease – implications for immunotherapy
202012 citationsauthor #1
Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
2020100 citationsauthor #1
Reduced IκB-α Protein Levels in Peripheral Blood Cells of Patients with Multiple Sclerosis—A Possible Cause of Constitutive NF-κB Activation
20208 citationsauthor #3
Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types
202019 citationsauthor #3
A Higher Mediterranean Diet Score, Including Unprocessed Red Meat, Is Associated with Reduced Risk of Central Nervous System Demyelination in a Case-Control Study of Australian Adults.
201947 citationsauthor #14
Higher fish consumption and lower risk of central nervous system demyelination
201920 citationsauthor #16
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
2019233 citationsauthor #2
Preliminary safety and efficacy of ATA188, a pre-manufactured, unrelated donor (off-the-shelf, allogeneic) Epstein-Barr virus-targeted T-cell immunotherapy for patients with progressive forms of multiple sclerosis
20198 citationsauthor #1
PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations
201826 citationsauthor #4
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
201842 citationsauthor #1
Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis.
201812 citationsauthor #5
A United States Patent ( 19 ) 11 Patent Number : 6 , 132 , 109
20170 citationsauthor #3
Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosis
20174 citationsauthor #1
Incidence and prevalence of NMOSD in Australia and New Zealand
2017110 citationsauthor #43
Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis
2017139 citationsauthor #1
Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trial
20171 citationsauthor #1
Stressful life events and the risk of initial central nervous system demyelination
201718 citationsauthor #9
Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid Disease
201712 citationsauthor #3
Saliva-derived DNA performs well in large-scale, high-density SNP microarray studies
20170 citationsauthor #52
Population attributable fractions and joint effects of key risk factors for multiple sclerosis
201665 citationsauthor #7
Functional effects of antibodies specific for myelin proteolipid protein in multiple sclerosis
20160 citationsauthor #5
Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
201479 citationsauthor #1
Characterization of genetic variants in the NFKBIA promoter region in multiple sclerosis
20141 citationsauthor #4
PLP1 mutations in patients with multiple sclerosis: Identification of a new mutation and analysis of in vitro effects of PLP1 mutations
20140 citationsauthor #3
Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.
201425 citationsauthor #5
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis
201477 citationsauthor #1
Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy
2014143 citationsauthor #1
Epstein-Barr virus-specific adoptive immunotherapy: a new horizon for multiple sclerosis treatment?
20146 citationsauthor #1
The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: The Ausimmune study
201333 citationsauthor #11
Sun Exposure over a Lifetime in Australian Adults from Latitudinally Diverse Regions
201326 citationsauthor #5
Early‐life hygiene‐related factors affect risk of central nervous system demyelination and asthma differentially
201319 citationsauthor #5
Vitamin D status: multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradient.
201383 citationsauthor #8
Consistent patterns of clinical and laboratory findings in patients with co-existent autoimmune thyroid disease and autoimmune demyelinating disease in the central nervous system
20121 citationsauthor #2
Building the hypothesis: CD8 T cell deficiency impairs immune control of Epstein-Barr virus infection in multiple sclerosis and worsens with age
20120 citationsauthor #2
Adherence to MRI protocol consensus guidelines in multiple sclerosis: An Australian multi‐centre study
201216 citationsauthor #14
CD8+ T cells far predominate over CD4+ T cells in healthy immune response to Epstein-Barr virus infected lymphoblastoid cell lines.
20126 citationsauthor #1
Epstein-Barr virus in the multiple sclerosis brain - An evasive culprit.
20120 citationsauthor #1
Interleukin-6 Gene Promoter-572 C Allele may Play a Role in Rate of Disease Progression in Multiple Sclerosis
201218 citationsauthor #5
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis
2012185 citationsauthor #1
Offspring number, pregnancy, and risk of a first clinical demyelinating event
2012126 citationsauthor #6
The role of latitude, ultraviolet radiation exposure and vitamin D in childhood asthma and hayfever: an Australian multicenter study
201189 citationsauthor #10
Sun exposure and vitamin D are independent risk factors for CNS demyelination
2011337 citationsauthor #5
CD8 T cell deficiency impairs control of Epstein–Barr virus and worsens with age in multiple sclerosis
201127 citationsauthor #1
Spasticity andwhite matterabnormalities in adult phenylketonuria
20110 citationsauthor #5
Epstein–Barr virus and multiple sclerosis
201155 citationsauthor #7
Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes
201117 citationsauthor #1
Current and past Epstein-Barr virus infection in risk of initial CNS demyelination
201177 citationsauthor #5
The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis
2011153 citationsauthor #1
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci | NOVA. The University of Newcastle's Digital Repository
20110 citationsauthor #44
Elevated levels of autoantibodies against neurotransmitter receptor-related molecules in schizophrenia
20100 citationsauthor #3
Investigation of the [−/A]8 and C1236T genetic variations within the human toll-like receptor 3 gene for association with multiple sclerosis
20105 citationsauthor #7
Strains of Epstein-Barr virus infecting multiple sclerosis patients
201031 citationsauthor #9
Latitudinal variation in incidence and type of first central nervous system demyelinating events
2010101 citationsauthor #5
Latitudinal variation in incidence and type of first central nervous system demyelinating events | NOVA. The University of Newcastle's Digital Repository
20100 citationsauthor #8
Investigation of the role of pregnancy and exposure to biological children in the onset of central nervous system demyelination
20100 citationsauthor #14
Is Wikipedia unsuitable as a clinical information resource for medical students?
200922 citationsauthor #1
Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population.
20091 citationsauthor #8
CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia.
200915 citationsauthor #6
Polymorphic investigation within the region of several sex hormone genes for association with multiple sclerosis within an Australian case-control population
20090 citationsauthor #7
Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.
200968 citationsauthor #1
Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis?
200936 citationsauthor #1
An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population.
200918 citationsauthor #7
Associations between Silicone Skin Cast Score, Cumulative Sun Exposure, and Other Factors in the Ausimmune Study: A Multicenter Australian Study
200952 citationsauthor #10
Lower vitamin D status at first clinical diagnosis of central nervous system demyelination compared to matched controls
20091 citationsauthor #5
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
2009553 citationsauthor #42
Association between actinic damage, a biomarker of lifetime sun exposure, and first clinical diagnosis of central nervous system demyelination: the Ausimmune Study
20082 citationsauthor #9
Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
200847 citationsauthor #2
and Lesion Localization in Multiple SclerosisType Reactivity to Myelin Proteins with HLA Correlation of Blood T Cell and Antibody
20080 citationsauthor #1
Correlation of Blood T Cell and Antibody Reactivity to Myelin Proteins with HLA Type and Lesion Localization in Multiple Sclerosis1
200844 citationsauthor #4
Putting Wikipedia to the Test: A Case Study
20089 citationsauthor #1
Latitudinal variation in incidence of first demyclinating events: descriptive analyses of case participants in the Ausimmune Study
20084 citationsauthor #10
Decreased T cell reactivity to Epstein–Barr virus infected lymphoblastoid cell lines in multiple sclerosis
2008103 citationsauthor #1
Infection with specific strains of Epstein-Barr virus are a risk factor for multiple sclerosis
20080 citationsauthor #6
Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population.
20076 citationsauthor #8
Immunology of multiple sclerosis
200736 citationsauthor #1
No association between MTHFR A1298C and MTRR A66G polymorphisms, and MS in an Australian cohort.
200728 citationsauthor #7
Treating autoimmune demyelination by augmenting lymphocyte apoptosis in the central nervous system.
200724 citationsauthor #1
Tonic spasms and demyelinating lesions
20070 citationsauthor #1
No association between MTHFR A1298C and MTRR A66G polymorphisms, and MS in an Australian cohort.
200728 citationsauthor #8
Lower motor neuron weakness after diving-related decompression
20060 citationsauthor #2
Association of the Vitamin D Receptor Gene with Multiple Sclerosis
20060 citationsauthor #7
Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function
200675 citationsauthor #10
Multiple Sclerosis: Early Diagnosis and Comprehensive Management
20061 citationsauthor #1
T-cell apoptosis in human glioblastoma multiforme: implications for immunotherapy.
200650 citationsauthor #4
Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis.
200636 citationsauthor #9
Blood-brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement.
200567 citationsauthor #2
polyradiculoneuropathy chronic inflammatory demyelinating and protein in patients with Guillain-Barré syndrome T cell reactivity to P0, P2, PMP-22, and myelin basic
20051 citationsauthor #3
VARIATION IN THE VITAMIN D RECEPTOR GENE IS ASSOCIATED WITH MULTIPLE SCLEROSIS IN AN AUSTRALIAN POPULATION
2005139 citationsauthor #7
POSSIBLE MECHANISMS BY WHICH EBV INFECTION COULD PROMOTE AUTOIMMUNE DISEASE
20052 citationsauthor #1
The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRβ1 chain is associated with the clinical course of multiple sclerosis
200532 citationsauthor #2
Subject Index Vol. 53, 2005
20050 citationsauthor #54
Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barré syndrome.
200528 citationsauthor #5
Increased constitutive activation of NF-kappa B in patients with multiple sclerosis
20050 citationsauthor #5
Multiple Sclerosis with Idiopathic Dilated Cardiomyopathy: A Case Report
20054 citationsauthor #2
CSF testing for multiple sclerosis.
20052 citationsauthor #1
Levels of constitutively activated NF-kB are increased and IB levels are decreased in T cells and macrophages from patients with multiple sclerosis
20050 citationsauthor #5
Contents Vol. 53, 2005
20051 citationsauthor #54
T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
200589 citationsauthor #4

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT